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Abstract
Background:  Cytoreductive surgery and intraoperative, intraperitoneal hyperthermic
chemoperfusion (HIPEC) is increasingly used to treat peritoneal surface metastases. We describe
a fatal case of cerebral edema in a patient with appendiceal carcinoma and an underlying seizure
disorder who underwent cytoreductive surgery and HIPEC.
Case presentation: A case of fatal postoperative cerebral edema is presented in a patient with
an underlying seizure disorder and recurrent mucinous adenocarcinoma of the appendix. The
patient was treated with cytoreductive surgery and intraoperative intraperitoneal hyperthermic
chemoperfusion. The details and implications of this complication are discussed.
Conclusion: The recognition of this potential complication is important for physicians performing
cytoreductive surgery and HIPEC. Special caution should be taken when patients with seizure
disorders are being considered for this treatment.
Background
The treatment of peritoneal metastases remains one of the
most challenging problems in clinical oncology. Over the
last decade, interest in the use of aggressive cytoreductive
surgery combined with hyperthermic intraperitoneal
intraoperative chemotherapy (HIPEC) has increased [1].
This interest has been fueled by data from single institu-
tions and collected series demonstrating long-term sur-
vival for selected patients with peritoneal surface
metastases treated with this combined modality approach
[2]. Along with the availability of new cytotoxic and bio-
logic therapies for gastrointestinal cancers, recent data
demonstrating improved survival for ovarian cancer
patients treated with postoperative intraperitoneal ther-
apy has only served to increase the interest in such treat-
ment for patients with GI malignancies [3-6].
To date, there has been only a single large randomized
study, which demonstrated a benefit for patients with
colon carcinoma treated with cytoreductive surgery,
HIPEC and systemic chemotherapy versus palliative sur-
gery and chemotherapy alone [3]. Not surprisingly, the
most successful outcomes for cytoreduction and HIPEC
have been achieved in patients with low-grade malignan-
cies of the appendix [7]. These tumors have a propensity
to metastasize solely to peritoneal surfaces, and thus are
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an ideal tumor type to apply aggressive surgery and intra-
peritoneal therapies. Along with tumor grade, the com-
pleteness of cytoreduction appears to most strongly
correlate with patient outcome [8]. Current practice for
HIPEC involves either an open abdomen or closed abdo-
men into which the chemotherapeutic agent(s) are heated
to approximately 41°C. Mitomycin and cisplatin are the
most commonly used chemotherapeutic agents. HIPEC
using these agents results in major morbidity in approxi-
mately one third of patients and mortality rates range
from 0–12% in recent series [9,10]. Common complica-
tions include intraabdominal abscess/fistula, pulmonary
embolism and neutropenia. Here we present a case of
death secondary to cerebral edema in a patient who
underwent cytoreductive surgery + HIPEC for recurrent
appendiceal carcinoma with Mitomycin C.
Case presentation
A 37 year old female presented to her primary care physi-
cian with nonspecific abdominal pain. She underwent CT
imaging that revealed bilateral ovarian masses and ascites.
Preoperative CA125 was the only tumor marker examined
and it was within normal limits. A presumptive diagnosis
of ovarian cancer was made and she underwent explora-
tory laparotomy which revealed macroscopic peritoneal
metastases to ovaries, omentum and pelvic peritoneum.
At that time total abdominal hysterectomy, bilateral salp-
ingoopherectomy, pelvic lymph node sampling, partial
omentectomy, appendectomy and evacuation of muci-
nous ascites was performed. Final pathology revealed low
grade mucinous adenocarcinoma in all specimens, arising
from an appendiceal primary. The patient received no
additional therapy and was followed clinically. She devel-
oped recurrent abdominal pain approximately 2 years
later. Computed tomography (CT) scan revealed progres-
sive nodularity in the mesentery and peritoneal surfaces
consistent with recurrent disease. This was further evalu-
ated with a laparoscopy, which revealed mucinous tumor
implants along the anterior abdominal wall, right retro-
peritoneum, diaphragm, and remaining omentum (Fig-
ure 1A,B). At this time, the patient was referred to the
University of Cincinnati for consideration of cytoreduc-
tive surgery and intraperitoneal hyperthermic chemoper-
fusion. The patient's past medical history was significant
only for a seizure disorder which was managed by anti-
convulsant medication and an implanted vagus nerve
stimulator. Preoperative CA19-9 was elevated at 59, while
CEA and CA-125 were normal. The patient was felt to be
an appropriate candidate and underwent exploration. At
surgery, extensive disease was noted over the peritoneal
surfaces. A complete cytoreduction was achieved requir-
ing, right colectomy, splenectomy, cholecystectomy,
omentectomy, and perionectomies of the diaphragms,
anterior abdominal wall, and pelvis. Tumor nodules were
excised from the small bowel and large bowel mesentery.
The cytoreductive portion of the operation was completed
in approximately 210 minutes. Per our current practice
protocol, a 90 minute perfusion was performed using an
inflow temperature of 44°C, with peritoneal surface tem-
peratures averaging 40.5–41.5°C. Intraperitoneal temper-
atures were measured via four temperature probes, one
within the liver parenchyma, and three within separate
quadrants of the peritoneum. Core temperature was
recorded via the bladder and esophageal temperature
probes. Per our standard protocol, the carrier solution was
peritoneal dialysis fluid (2.5%). The patient's maximum
recorded core body temperature during the procedure was
38.7°C and the maximum recorded liver temperature was
38.8°C. Mitomycin C was delivered using a total dose of
10 mg/L perfusate, delivered in divided doses of 7 mg/L at
initiation and redosed after 45 minutes at 3 mg/L. A total
dose of 45 mg was delivered in this patient. During the
operation, the patient had no significant electrolyte
abnormalities aside from the expected glucose elevation
seen during the perfusion period. The maximum serum
glucose was 355 mg/dL and the lowest serum sodium was
135. The operation was generally uneventful; no blood
transfusions were required and the patient was transferred
to the ICU in stable condition. Postoperatively, all serum
electrolytes were normal and albumin was 3.4 mg/dl com-
pared with 4.3 mg/dl, preoperatively. The patient was eas-
ily arousable and followed commands appropriately.
However, approximately 4 hrs later, the patient com-
plained of headache and right eye pain. Her headache was
treated with analgesics, however 3 hours later, she was
found to be tachypenic, bradycardic, and hypotensive,
and was unresponsive with fixed, dilated pupils. She was
emergently intubated and resuscitated. After approxi-
mately 15 minutes, she regained consciousness, and
responded appropriately to commands. Her pupils
returned to 3 mm and because reactive. Neurology was
consulted and she was loaded with Dilantin due to her
history of seizure disorder. An urgent CT scan was
ordered. On route to the CT scanner, she once again
became bradycardic and hypotensive with fixed, dilated
pupils. The CT scan revealed diffuse cerebral edema (Fig-
ure 2). ICP monitoring revealed pressures of 70–90
mmHg. Mannitol was used in an attempt to lower intrac-
ranial pressure without success. EEG was consistent with
diffuse brain dysfunction. A brain death protocol revealed
that she had suffered brain death and care was subse-
quently withdrawn. At autopsy, diffuse cerebral edema
with tonsillar herniation was noted (Figure 3). No patho-
logic findings were present to indicate the cause of the cer-
ebral edema. The final pathology on all resected
specimens reconfirmed the diagnosis of mucinous adeno-
carcinoma (Figure 4A,B).World Journal of Surgical Oncology 2006, 4:85 http://www.wjso.com/content/4/1/85
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A) Laparoscopic view of the cecum demonstrating foci of recurrent appendiceal mucinous tumor Figure 1
A) Laparoscopic view of the cecum demonstrating foci of recurrent appendiceal mucinous tumor. B) Laparoscopic view of the 
anterior abdominal wall demonstrating recurrent mucinous tumor adherent to the parietal peritoneum. Note evidence of 
more solid tumor deposits suggesting the presence of adenocarcinoma as opposed to simple adenomucinosis.
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Discussion
Studies of HIPEC have revealed characterized several alter-
ations in the physiology of patients during this treatment.
Core body temperature is seen to increase significantly,
but can usually be maintained in acceptable range by pre-
cooling and/or through the use of external cooling meas-
ures. Heart rate, CVP and PAP also increase, yet MAP, CO,
oxygen delivery, and oxygen consumption do not change
significantly [11,12]. Transient hyperglycemia occurs pre-
sumably secondary both to the stress response from sur-
gery and hyperthermia, and to the presence of dextrose in
the perfusate. In our patient, electrolytes remained within
the normal range. The expected transient hyperglycemia
responded appropriately to insulin. Core temperature
peaked at 38.7°C and subsequently returned to normal.
These are not likely to have contributed to the acute cere-
bral edema that she suffered.
Seizures are temporary abnormal electrophysiologic phe-
nomena of the brain that result in abnormal synchroniza-
tion of electrical neuronal activity. They can manifest as
an alteration in mental state, tonic or clonic movements
and various other symptoms.
When seizure activity is continuous it is referred to as sta-
tus epilepticus. This persistent condition can lead to neu-
ronal injury. Generalized convulsive status epilepticus
(GCSE) is the most common form and is associated with
a significant risk of mortality. All other forms of status epi-
lepticus are grouped as nonconvulsive status epilepticus.
Etiologies may include high fever and infection in chil-
dren, electrolyte abnormalities, previous CNS insult, and
hypoxia [13].
Acute brain swelling occurs is seen in a variety of clinical
settings. Systemic complications of brain swelling include
fever, lactic acidosis, hyperglycemia, respiratory difficul-
ties, and cardiovascular changes [14,15]. In one animal
study, persistent seizures resulted in generalized cerebral
edema at 2 hours and necrotic edema at 24 hours [15].
Acute cerebral edema has been documented after general-
ized convulsive status epilepticus. Our patient suffered
from complex partial seizures. We were unable to find evi-
dence of cerebral edema occurring in a patient with com-
plex partial epilepticus. In a case report, transient seizure-
induced MR enhancement consistent with ictal or postic-
tal hyperemia in patients with complex partial seizures
was reported. However, there changes were noted to be
transient [16]. Despite the absence of reports, it remains a
possibility that in this patient, acute cerebral edema may
have occurred secondary to unrecognized partial complex
seizures in a patient whose seizure threshold may have
been lowered secondary to the stress of surgery and hyper-
thermia. Patients with documented complex partial sei-
zure may have confusion as the only manifestation of
their seizure activity and thus it is possible to miss the
only clinical signs. However, the postoperative EEG in our
patient showed no evidence of status epilepticus, thus
arguing against this explanation. Additionally, there have
been no reports of any association between the presence
of a vagus nerve stimulator and acute cerebral edema.
Hyperthermia is reported to predispose the brain to
hypoxic/anoxic injury. In our patient, systemic hyperther-
mia never reached critical levels and had resolved post-
operatively. There were no instances of hypoxia in this
patient. Thus, unfortunately the etiology of the cerebral
edema remains unclear. Given the increasing use of
HIPEC, we believe the documentation of unusual compli-
cations such as this is important in the consideration of
operative risk and for informed consent in future patients
with peritoneal surface metastases.
As a result of this event, our group has now incorporated
preoperative consultation with a neurologist to insure
adequacy of preoperative anticonvulsant therapy and to
Diffuse cerebral edema resulting in compression of ventricles Figure 2
Diffuse cerebral edema resulting in compression of ventri-
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comment on the possible value of intraoperative EEG
monitoring prior to considering HIPEC in any patient
with a history of seizures.
Conclusion
This article represents the first description of fatal cerebral
edema following treatment of appendiceal carcinoma
with intraperitoneal hyperthermic chemoperfusion. This
complication occurred in a patient with an underlying sei-
zure disorder and raises the question as to whether this
may have been a causative factor. The recognition of this
potential complication is important for physicians per-
forming cytoreductive surgery and HIPEC. Special caution
should be taken when patients with seizure disorders are
being considered for this treatment.
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Coronal section demonstrating normal grey and white matter with marked loss of luminal dimension in the ventricular system  due to diffuse cortical edema Figure 3
Coronal section demonstrating normal grey and white matter with marked loss of luminal dimension in the ventricular system 
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A) Foci of adenocarcinoma from the right colon demonstrating large amounts of mucin on the serosal surface Figure 4
A) Foci of adenocarcinoma from the right colon demonstrating large amounts of mucin on the serosal surface. B) Multiple foci 
of mucinous adenocarcinoma with Mib-1 staining, indicating a high proliferative rate.
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